Suppr超能文献

金纳米棒与 GD2 单克隆抗体结合在近红外激光辐射下的抗神经母细胞瘤活性。

Anti-Neuroblastoma Activity of Gold Nanorods Bound with GD2 Monoclonal Antibody under Near-Infrared Laser Irradiation.

机构信息

Department of Chemical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, USA.

出版信息

Cancers (Basel). 2011 Jan 6;3(1):227-40. doi: 10.3390/cancers3010227.

Abstract

High-risk neuroblastoma is one of the most common deaths in pediatric oncology. Current treatment of this disease involves a coordinated sequence of chemotherapy, surgery, and radiation. Further advances in therapy will require the targeting of tumor cells in a more selective and efficient way so that survival can be improved without substantially increasing toxicity. To achieve tumor-selective delivery, disialoganglioside (GD2) expressed by almost all neuroblastoma tumors represents a potential molecular target that can be exploited for tumor-selective delivery. In this study, GD2 monoclonal antibody (anti-GD2) was conjugated to gold nanorods (GNRs) which are one of anisotropic nanomaterials that can absorb near-infrared (NIR) laser light and convert it to energy for photothermolysis of tumor cells. Thiolated chitosan, due to its biocompatibility, was used to replace cetyltrimethylammonium bromide (CTAB) originally used in the synthesis of gold nanorods. In order to specifically target GD2 overexpressed on the surface of neuroblastoma stNB-V1 cells, anti-GD2 was conjugated to chitosan modified GNRs (CGNRs). To examine the fate of CGNRs conjugated with anti-GD2 after incubation with neuroblastoma cells, rhadoamine B was labeled on CGNRs functionalized with anti-GD2. Our results illustrated that anti-GD2-conjugated CGNRs were extensively endocytosed by GD2+ stNB-V1 neuroblastoma cells via antibody-mediated endocytosis. In addition, we showed that anti-GD2 bound CGNRs were not internalized by GD2- SH-SY5Y neuroblastoma cells. After anti-GD2-linked CGNRs were incubated with neuroblatoma cells for six hours, the treated cells were further irradiated with 808 nm NIR laser. Post-NIR laser exposure, when examined by calcein-AM dye, stNB-V1 cells all underwent necrosis, while non-GD2 expressing SH-SY5Y cells all remained viable. Based on the in vitro study, CGNRs bound with anti-GD2 has the potential to be utilized as a therapeutic thermal coupling agent that generates heat sufficient to selectively kill neuroblastoma cells under NIR laser light exposure.

摘要

高危神经母细胞瘤是小儿肿瘤学中最常见的死亡原因之一。目前对这种疾病的治疗涉及化疗、手术和放疗的协调序列。治疗的进一步进展将需要以更具选择性和更有效的方式靶向肿瘤细胞,以便在不显著增加毒性的情况下提高生存率。为了实现肿瘤选择性递药,几乎所有神经母细胞瘤肿瘤表达的二唾液酸神经节苷脂(GD2)代表了一个潜在的分子靶点,可以用于肿瘤选择性递药。在这项研究中,GD2 单克隆抗体(抗-GD2)与金纳米棒(GNRs)偶联,GNRs 是一种各向异性纳米材料,能够吸收近红外(NIR)激光并将其转化为肿瘤细胞光热解的能量。由于其生物相容性,巯基化壳聚糖被用于替代最初用于金纳米棒合成的十六烷基三甲基溴化铵(CTAB)。为了特异性地靶向神经母细胞瘤 stNB-V1 细胞表面过表达的 GD2,将抗-GD2 与壳聚糖修饰的 GNRs(CGNRs)偶联。为了研究与神经母细胞瘤细胞孵育后偶联抗-GD2 的 CGNRs 的命运,用 rhadoamine B 标记了用抗-GD2 功能化的 CGNRs。我们的结果表明,抗-GD2 偶联的 CGNRs 通过抗体介导的内吞作用被 GD2+ stNB-V1 神经母细胞瘤细胞广泛内化。此外,我们表明,GD2 结合的 CGNRs 不会被 GD2-SH-SY5Y 神经母细胞瘤细胞内化。将抗-GD2 偶联的 CGNRs 与神经母细胞瘤细胞孵育 6 小时后,用 808nm NIR 激光进一步照射处理后的细胞。在近红外激光照射后,用 calcein-AM 染料检测时,stNB-V1 细胞均发生坏死,而不表达 GD2 的 SH-SY5Y 细胞均保持存活。基于体外研究,与抗-GD2 结合的 CGNRs 有可能被用作治疗性热偶联剂,在 NIR 激光照射下产生足够的热量以选择性杀死神经母细胞瘤细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85e0/3756358/a0207df28f71/cancers-03-00227f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验